Baylor College of Medicine — Biomedical Watch V2

Essais liés34clinical trials

VilleHoustonlocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07667478

Ouvrir le site du centre

Essais cliniques associés

Molécule	Indication / population	Phase	NCT	Titre	Statut
BIA 28-6156 10 mg	Parkinson	Phase 2	NCT05819359	ACTIVATE — Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD	COMPLETED
zagociguat 15mg	Myopathies	Phase 2	NCT06961344	An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)	TERMINATED
Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System	Insuffisance cardiaque	Non applicable	NCT05064709	AIM HIGHer — Assessment of CCM in HF With Higher Ejection Fraction	RECRUITING
Synchronized Diaphragmatic Stimulation	Insuffisance cardiaque	Non applicable	NCT06552637	RECOVER-HF — Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure	RECRUITING
CK0803	Sclérose latérale amyotrophique	Phase 1	NCT05695521	REGALS — Regulatory T Cells for Amyotrophic Lateral Sclerosis	ACTIVE_NOT_RECRUITING
AFSW Guided DOAC	Accident vasculaire cérébral	Phase 3	NCT05836987	REACT-AF — The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation	RECRUITING
Pelacarsen (TQJ230)	Accident vasculaire cérébral	Phase 3	NCT07517263	An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)	ACTIVE_NOT_RECRUITING
zagociguat 15mg	Accident vasculaire cérébral	Phase 2	NCT06402123	PRIZM — A Phase 2b Study of Zagociguat in Patients With MELAS	COMPLETED
Repetitive Transcranial Magnetic Stimulation (rTMS)	Alzheimer	Non applicable	NCT07667478	NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE	RECRUITING
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications	Parkinson	À vérifier	NCT07330258	A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications	RECRUITING
Lab Assay for seven genetic variants for Parkinson's Disease	Parkinson	À vérifier	NCT04994015	Parkinson's Foundation PD GENEration Genetic Registry	RECRUITING
Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma	Cancer	À vérifier	NCT03878550	Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma	ACTIVE_NOT_RECRUITING
Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease	Alzheimer	Phase 1	NCT04740580	Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease	ACTIVE_NOT_RECRUITING
NEU-411	Parkinson	Phase 2	NCT06680830	NEULARK — A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease	RECRUITING
ELEVIDYS	Myopathies	Phase 4	NCT07542314	ENHANCE — Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting	RECRUITING
Placement of the BrainGate2 sensor(s) into the motor-related cortex	Myopathies	Non applicable	NCT00912041	BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia	RECRUITING
Brain Interchange System	Épilepsie	Non applicable	NCT05439655	Acute Recording of Stereotyped High-Frequency Oscillations	ACTIVE_NOT_RECRUITING
Solanezumab	Alzheimer	Phase 3	NCT02008357	A4 — Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss	COMPLETED
Speedboat™ Ultraslim	Cancer	À vérifier	NCT06476678	Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions	RECRUITING
Neuraceq	Alzheimer	À vérifier	NCT05617014	ADNI4 — Alzheimer's Disease Neuroimaging Initiative 4	ENROLLING_BY_INVITATION
3T Magnetic Resonance Imaging (MRI)	Épilepsie	À vérifier	NCT05823766	Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)	ACTIVE_NOT_RECRUITING
Tazbentetol	Sclérose latérale amyotrophique	À vérifier	NCT07088159	Intermediate-size Patient Population Expanded Access Protocol	AVAILABLE
Vonsetamig	Lupus	Phase 1	NCT06975787	Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis	RECRUITING
high-intensity focused ultrasound ablation	Cancer	Phase 3	NCT00005075	Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer	TERMINATED
RAP-219	Épilepsie	Phase 3	NCT07594119	FOCUS 2 — Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures	RECRUITING
EEG	Épilepsie	Non applicable	NCT06934356	Subcortical Arousal in Perceptual Awareness	RECRUITING
Brain Interchange System	Épilepsie	Non applicable	NCT06898138	Acute Stimulation and Modulation of Stereotyped High-Frequency Oscillations	NOT_YET_RECRUITING
CT1812	Alzheimer	Phase 2	NCT05531656	A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease	ACTIVE_NOT_RECRUITING
Ocrelizumab	SEP	Phase 3	NCT05269004	OLERO — A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis	ACTIVE_NOT_RECRUITING
Anti-hypertensive therapy	Hypertension	Phase 4	NCT02299414	Chronic Hypertension and Pregnancy (CHAP) Project	COMPLETED
Interferon beta-1a	SEP	Phase 3	NCT01412333	A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis	COMPLETED
ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	Alzheimer	À vérifier	NCT01078636	ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	COMPLETED
Zilucoplan	Sclérose latérale amyotrophique	Phase 2/3	NCT04297683	HEALEY ALS Platform Trial - Master Protocol	ACTIVE_NOT_RECRUITING
RNS® System	Épilepsie	Phase 4	NCT00572195	RNS® System LTT Study	COMPLETED